In vitro release testing of matrices based on starch-methyl methacrylate copolymers: Effect of tablet crushing force, dissolution medium pH and stirring rate

International Journal of Pharmaceutics

Volumn 461, Issue 1-2, 2014, Pages 270-279

  Ferrero, C ^a   Jimenez Castellanos M R ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Drug release kinetics; pH changing medium; Potato starch methyl methacrylate copolymers; Stirring rate; Sustained release matrix tablet; Tablet crushing force

Indexed keywords

COPOLYMER; MERCURY; METHACRYLIC ACID METHYL ESTER; POTATO STARCH; THEOPHYLLINE; DELAYED RELEASE FORMULATION; POLYMER; STARCH; TABLET;

ARTICLE; DRUG DIFFUSION; DRUG SOLUBILITY; HYDRODYNAMICS; IN VITRO STUDY; PH; PRIORITY JOURNAL; ROTATION; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET CRUSHING FORCE; TABLET FORMULATION; TABLET POROSITY; TABLET THICKNESS; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFUSION; KINETICS; MEDICINAL CHEMISTRY; POROSITY; POTATO; PROCEDURES; SOLUBILITY; TABLET; THEORETICAL MODEL;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; HYDROGEN-ION CONCENTRATION; KINETICS; METHYLMETHACRYLATE; MODELS, THEORETICAL; POLYMERS; POROSITY; SOLANUM TUBEROSUM; SOLUBILITY; STARCH; TABLETS; THEOPHYLLINE;

EID: 84891542169     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.12.001     Document Type: Article

References (38)

1. M. Ashford The gastrointestinal tract-physiology and drug absorption M.E. Aulton, Pharmaceutics: The Science of Dosage form Design 2002 Churchill Livingstone Edinburgh 217 233
2. E. Assaad, and M.A. Mateescu The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: structural insights and drug release kinetics Int. J. Pharm. 394 2010 75 84
3. G.K. Bolhuis, and C.F. Lerk Comparative evaluation of excipients for direct compression Pharm. Weekblad. 108 1973 469 481
4. I. Bravo-Osuna, C. Ferrero, and M.R. Jiménez-Castellanos Water sorption-desorption behaviour of methyl methacrylate-starch copolymers: effect of hydrophobic graft and drying method Eur. J. Pharm. Biopharm. 59 2005 537 548 (Pubitemid 40342528)
5. I. Castellano, M. Gurruchaga, and I. Goñi The influence of drying method on the physical properties of some graft copolymers for drug delivery systems Carbohydr. Polym. 34 1997 83 89 (Pubitemid 127376295)
6. A. Ceballos, M. Cirri, F. Maestrelli, G. Corti, and P. Mura Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets Il Farmaco 60 2005 913 918 (Pubitemid 41586266)
7. A.E. Clausen, and A. Bernkop-Schnürch Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery J. Control. Release 75 2001 93 102 (Pubitemid 32635200)
8. J.P. Crombeen, and C.J. De Blaey In vitro testing of controlled release preparations: Theolair®, Theograd® and Theolin® Pharm. Weekblad. 5 1983 65 69
9. M.M. Crowley, B. Schroeder, A. Fredersdorf, S. Obara, M. Talarico, S. Kucera, and J.W. McGinity Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion Int. J. Pharm. 269 2004 509 522 (Pubitemid 38045312)
10. S.J. Desai, P. Singh, A.P. Simonelli, and W.I. Higuchi Investigation of factors influencing release of solid drug dispersed in inert matrices. IV. Some studies involving the polyvinyl chloride matrix J. Pharm. Sci. 55 1966 1235 1239
11. M. Efentakis, and S. Politis Comparative evaluation of various structures in polymer controlled drug delivery systems and the effect of their morphology and characteristics on drug release Eur. Polym. J. 42 2006 1183 1195
12. European Agency for the Evaluation of Medicinal Products (EMEA) Human medicines evaluation unit. Note for guidance on quality of modified release products: A. oral dosage forms, B. transdermal dosage forms 1999 Section 1 (Quality), CPMP/QWP/604/96
13. European Directorate for the Quality of Medicines, 2011. European Pharmacopoeia, seventh ed. Council of Europe, Strasbourg, France.
14. FDA's Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation 1997 Center for Drug Evaluation and Research (CDER) Rockville www.fda.gov/cder/guidance/index.htm
15. M.C. Ferrero, M.V. Velasco, J.L. Ford, A.R. Rajabi-Siahboomi, A. Muñoz, and M.R. Jiménez-Castellanos Determination of the glass transition temperatures of some new methyl methacrylate copolymers using modulated temperature differential scanning calorimetry (MTDSC) Pharm. Res. 16 1999 1464 1469 (Pubitemid 29449387)
16. C. Ferrero, and M.R. Jiménez-Castellanos The influence of carbohydrate nature and drying methods on the compaction properties and pore structure of new methyl methacrylate copolymers Int. J. Pharm. 248 2002 157 171 (Pubitemid 35341420)
17. C. Ferrero, I. Bravo, and M.R. Jiménez-Castellanos Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity J. Control. Release 92 2003 69 82 (Pubitemid 37130122)
18. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
19. E.D. Jorgensen, and D. Bhagwat Development of dissolution tests for oral extended-release products Pharm. Sci. Technol. Today 1 1998 128 135 (Pubitemid 28326334)
20. N. Katori, N. Aoyagi, and T. Terao Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation Pharm. Res. 12 1995 237 243
21. P. Kleinebudde Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose. I. Shrinking properties Int. J. Pharm. 109 1994 209 219 (Pubitemid 24240116)
22. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharm. 15 1983 25 35 (Pubitemid 13092121)
23. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air J. Pharm. Sci. 72 1983 1189 1191 (Pubitemid 13013640)
24. V. Lenaerts, I. Moussa, Y. Dumoulin, F. Mebsout, F. Chouinard, P. Szabo, M.A. Mateescu, L. Cartilier, and R. Marchessault Cross-linked high amylose starch for controlled release of drugs: recent advances J. Control. Release 53 1998 225 234 (Pubitemid 28218705)
25. M. Morihara, N. Aoyagi, N. Kaniwa, N. Katori, and S. Kojim Hydrodynamic flows around tablets in different pharmacopeial dissolution tests Drug Dev. Ind. Pharm. 28 6 2002 655 662 (Pubitemid 34809564)
26. J. Mulhbacher, P. Ispas-Szabo, and M.A. Mateescu Cross-linked high amylose starch derivatives for drug release II. Swelling properties and mechanistic study Int. J. Pharm. 278 2004 231 238 (Pubitemid 38765160)
27. D.L. Munday, and A.R. Fassihi In vitro-in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets Int. J. Pharm. 118 1995 251 255
28. A. Muñoz-Ruiz, R. Gallego, M. del Pozo, M.R. Jiménez- Castellanos, and J. Domínguez-Abascal A comparison of three methods of estimating displacement on an instrumented single punch machine Drug Dev. Ind. Pharm. 21 1995 215 227
29. L. Ochoa, M. Igartua, R.M. Hernández, M.A. Solinís, A.R. Gascón, and J.L. Pedraz In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation Eur. J. Pharm. Biopharm. 75 2010 232 237
30. O.A. Odeku, W. Schmid, and K.M. Picker-Freyer Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches Eur. J. Pharm. Biopharm. 70 2008 357 371
31. S.-H. Park, M.-K. Chun, and H.-K. Choi Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex Int. J. Pharm. 347 2008 39 44 (Pubitemid 350180315)
32. S.I. Pather, I. Russell, J.A. Syce, and S.H. Neau Sustained release theophylline tablets by direct compression. Part 1. Formulation and in vitro testing Int. J. Pharm. 164 1998 1 10 (Pubitemid 28160092)
33. N.A. Peppas, and J.J. Sahlin A simple equation for the description of solute release. III. Coupling of diffusion and relaxation Int. J. Pharm. 57 1989 169 172 (Pubitemid 20011841)
34. P.L. Ritger, and N.A. Peppas A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs J. Control. Release 5 1987 23 26
35. J.-L. Salomon, and E. Doelker Formulation des comprimés à libération prolongée. I. Matrices inertes Pharm. Acta Helv. 55 1980 174 182
36. R.F. Shangraw Design and formulation of sustained release theophylline dosage forms Drug Dev. Ind. Pharm. 14 1988 319 335
37. Y. Wu, D.O. Kildsig, and E.S. Ghaly Effect of hydrodynamic environment on tablets dissolution rate Pharm. Dev. Technol. 9 2004 25 37 (Pubitemid 38250224)
38. B.D. Zdravkov, J.J. Čermák, M. Šefara, and J. Janků Pore classification in the characterization of porous materials: a perspective Cent. Eur. J. Chem. 5 2007 385 395